Kerry Jenkins,Christopher James Lock,Andrew James Ratcliffe
申请号：
US13124947
公开号：
US08653272B2
申请日:
2009.10.21
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A series of heteroaryl-substituted fused pyridine derivatives, in particular heteroaryl-substituted thieno[3,2-6]pyridine derivatives, being selective inhibitors of PO kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
